Chinese Biotech Readies Nasal Spray with Wegovy Ingredient, Eyes Global Trials by 2028
Novo Nordisk, whose semaglutide patent in China will expire in March, currently dominates the market with Wegovy.
Engineers and geoscientists can run simulations at greater speed, allowing them to test multiple scenarios in less time. This helps refine drilling strategies and improve production planning while reducing inefficiencies linked to slower analysis.
Novo Nordisk, whose semaglutide patent in China will expire in March, currently dominates the market with Wegovy.
This year proved that when you invest in people, culture, and meaningful support, extraordinary things happen. Our growt...
We will face unprecedented pressure to strengthen privacy protections and data governance frameworks in the coming year.
Careful planning and thoughtful diversification enable companies to enter new markets, capture untapped opportunities, a...